Amgen Inc (AMGN) — Quality & forensics

As of 2026-08-26 — refreshed nightly. Closelook readings from an investment research diary, not ratings or advice.

The Closelook module scores

54 /100 composite · 7 modules · general weight set

Valuation 62
Quality 85
Growth 42
Balance sheet 17
Cash quality 51
Capital allocation 43
Momentum 73

Scores are computed nightly across the coverage universe and read relative to it — the methodology lives in the company-scoring explainer.

Financial forensics — the academic screens

2.19 Altman Z-Score

Sits in the grey zone (1.81–2.99). The Z-Score estimates financial-distress risk from five balance-sheet and earnings ratios.

8/9 Piotroski F-Score

Nine binary fundamental-strength checks across profitability, leverage and operating efficiency.

-2.31 Beneish M-Score

Screens reported earnings for statistical manipulation patterns — below the −1.78 manipulation-risk threshold. A screen, not an accusation.

Continue: the AMGN chart & overview · AMGN on the tape

FAQ · from the current data · as of 2026-08-26

Quick answers

What is Amgen Inc's Closelook quality reading?

The composite reads 54/100 across 7 modules, as of 2026-08-26: valuation 62, quality 85, growth 42, balance sheet 17, cash quality 51, capital allocation 43, momentum 73. Closelook scores are research diary readings, not ratings or investment advice.

What is Amgen Inc's Altman Z-Score?

2.19, which sits in the grey zone (1.81–2.99) as of 2026-08-26. The Altman Z-Score estimates financial distress risk from five balance-sheet and earnings ratios.

What is Amgen Inc's Piotroski F-Score?

8 of 9, as of 2026-08-26. The F-Score counts nine binary fundamental-strength signals across profitability, leverage and operating efficiency.

What does Amgen Inc's Beneish M-Score indicate?

-2.31 — below the −1.78 manipulation-risk threshold, as of 2026-08-26. The M-Score screens reported earnings for statistical manipulation patterns; it is a screen, not an accusation.